SurgePays Inc. (SURG)
SurgePays Statistics
Share Statistics
SurgePays has 20.41M shares outstanding. The number of shares has increased by 5.15% in one year.
Shares Outstanding | 20.41M |
Shares Change (YoY) | 5.15% |
Shares Change (QoQ) | 1.24% |
Owned by Institutions (%) | 10.06% |
Shares Floating | 14.12M |
Failed to Deliver (FTD) Shares | 75.08K |
FTD / Avg. Volume | 4.59% |
Short Selling Information
The latest short interest is 1.43M, so 6.99% of the outstanding shares have been sold short.
Short Interest | 1.43M |
Short % of Shares Out | 6.99% |
Short % of Float | 9.67% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.74 and the forward PE ratio is 1.78. SurgePays's PEG ratio is 0.
PE Ratio | -0.74 |
Forward PE | 1.78 |
PS Ratio | 0.56 |
Forward PS | 0.2 |
PB Ratio | 2.22 |
P/FCF Ratio | -1.56 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for SurgePays.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.1.
Current Ratio | 2.95 |
Quick Ratio | 2.66 |
Debt / Equity | 0.1 |
Debt / EBITDA | -0.04 |
Debt / FCF | -0.07 |
Interest Coverage | -75.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $468.32K |
Profits Per Employee | $-351.76K |
Employee Count | 130 |
Asset Turnover | 2.54 |
Inventory Turnover | 42.22 |
Taxes
Income Tax | 2.87M |
Effective Tax Rate | -6.66% |
Stock Price Statistics
The stock price has increased by -21.7% in the last 52 weeks. The beta is 1.13, so SurgePays's price volatility has been higher than the market average.
Beta | 1.13 |
52-Week Price Change | -21.7% |
50-Day Moving Average | 1.67 |
200-Day Moving Average | 1.87 |
Relative Strength Index (RSI) | 70.47 |
Average Volume (20 Days) | 1.64M |
Income Statement
In the last 12 months, SurgePays had revenue of 60.88M and earned -45.73M in profits. Earnings per share was -2.39.
Revenue | 60.88M |
Gross Profit | -14.32M |
Operating Income | -41.78M |
Net Income | -45.73M |
EBITDA | -41.22M |
EBIT | -42.51M |
Earnings Per Share (EPS) | -2.39 |
Balance Sheet
The company has 11.79M in cash and 1.51M in debt, giving a net cash position of 10.28M.
Cash & Cash Equivalents | 11.79M |
Total Debt | 1.51M |
Net Cash | 10.28M |
Retained Earnings | -60.92M |
Total Assets | 23.98M |
Working Capital | 11.81M |
Cash Flow
In the last 12 months, operating cash flow was -21.31M and capital expenditures -518.19K, giving a free cash flow of -21.83M.
Operating Cash Flow | -21.31M |
Capital Expenditures | -518.19K |
Free Cash Flow | -21.83M |
FCF Per Share | -1.14 |
Margins
Gross margin is -23.53%, with operating and profit margins of -68.63% and -75.11%.
Gross Margin | -23.53% |
Operating Margin | -68.63% |
Pretax Margin | -70.74% |
Profit Margin | -75.11% |
EBITDA Margin | -67.71% |
EBIT Margin | -68.63% |
FCF Margin | -35.85% |
Dividends & Yields
SURG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for SURG is $8.5, which is 218.4% higher than the current price. The consensus rating is "Buy".
Price Target | $8.5 |
Price Target Difference | 218.4% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 2, 2021. It was a backward split with a ratio of 1:50.
Last Split Date | Nov 2, 2021 |
Split Type | backward |
Split Ratio | 1:50 |
Scores
Altman Z-Score | -2.82 |
Piotroski F-Score | 2 |